In early tests, Pfizer’s COVID-19 Vaccine proved effectiveness up to 90% – but why are more tests needed?
Preliminary results from Pfizer’s late-stage vaccine trial suggest that the vaccine can prevent COVID-19. The promising development comes at a time as the United States reached a grim moment of almost 10 million coronavirus cases, with around 238,000 deaths reported. The...